0000899243-22-016320.txt : 20220503
0000899243-22-016320.hdr.sgml : 20220503
20220503162833
ACCESSION NUMBER: 0000899243-22-016320
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220429
FILED AS OF DATE: 20220503
DATE AS OF CHANGE: 20220503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liu Joy
CENTRAL INDEX KEY: 0001847529
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 22887417
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-04-29
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001847529
Liu Joy
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP, General Counsel
Common Stock
2022-04-29
4
S
0
17
273.37
D
14437
D
Common Stock
2022-04-29
4
S
0
41
274.75
D
14396
D
Common Stock
2022-04-29
4
S
0
30
275.62
D
14366
D
Common Stock
2022-04-29
4
S
0
22
276.72
D
14344
D
Common Stock
2022-04-29
4
S
0
10
278.04
D
14334
D
Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $273.37 (range $273.13 to $273.87).
Open market sales reported on this line occurred at a weighted average price of $274.74 (range $274.20 to $275.14).
Open market sales reported on this line occurred at a weighted average price of $275.62 (range $275.22 to $276.19).
Open market sales reported on this line occurred at a weighted average price of $276.72 (range $276.31 to $277.06).
/s/ Sabrina Yohai, Attorney-in-Fact
2022-05-03